Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2010
05/26/2010EP2187924A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187917A2 Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agent
05/26/2010EP2187915A2 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent
05/26/2010EP2187909A1 Use of bpp-b as a therapeutic agent
05/26/2010EP2187901A2 Therapeutic use of neuropeptide ei and a acth 7-38 and compositions thereof
05/26/2010EP2187892A1 Method and means for the treatment of cachexia
05/26/2010EP2187742A1 Benzylbenzene derivatives and methods of use
05/26/2010EP1539137B1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
05/26/2010EP1461325B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/26/2010EP1424998B1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
05/26/2010EP1303495B1 Substituted 5-alkynyl pyrimidines having neurotrophic activity
05/26/2010CN1977884B Medicinal composition for treating diabetes and its preparing method
05/26/2010CN1972931B Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia
05/26/2010CN1942182B Inhibitors of dipeptidylpeptidase IV for regulating glucose metabolism
05/26/2010CN1922183B Nitrogenous fused heteroaromatic ring derivative
05/26/2010CN1915991B Synthesis of indole thiazole compounds as ligands for the ah receptor
05/26/2010CN1895546B Lycium chinensis polyose medicinal composition with therapeutic and health-care functions
05/26/2010CN1870982B Composition containing reduced coenzyme q
05/26/2010CN1853654B Oral preparation containing pearl and vitamine
05/26/2010CN1780826B Process for the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof
05/26/2010CN1771912B Orally taken nanometer protein polypetide composite nano-particle and its preparation
05/26/2010CN1741799B Combination of antidiabetic drugs
05/26/2010CN1736384B Mixture of higher primary aliphatic alcohols with acetylsalicylic acid and pharmaceutical formulation
05/26/2010CN1690057B Selenophen derivatives and their use for prevention and/or treatment of diseases relative to protein aging
05/26/2010CN1671407B Compositions and methods for treating diabetes
05/26/2010CN1646138B Novel therapeutical use of agonist ligands specific to G2A receptor
05/26/2010CN1642580B Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
05/26/2010CN1391469B Npyy5拮抗剂 Npyy5 antagonist
05/26/2010CN101715450A Azaindole derivatives as cftr modulators
05/26/2010CN101715347A A method for modifying polyphenol containing plant materials and medical uses of modified polyphenol plant containing materials
05/26/2010CN101712726A Method for preparing high-purity mulberry leaf polysaccharide
05/26/2010CN101712722A Glp-1 fusion proteins
05/26/2010CN101712720A Human antibodies that bind human TNF alpha
05/26/2010CN101712709A Tifluoroacetyl-3-hydroxyphenyl adenosine and use thereof in blood fat regulation
05/26/2010CN101712678A Tartrate salts of thiazolidinedione derivative
05/26/2010CN101712671A Daizeol aliphatic ester derivatives, preparing method and medical application thereof
05/26/2010CN101712669A Method for separating and purifying luteolin
05/26/2010CN101712657A heteroarylcarbamoylbenzene derivative
05/26/2010CN101712653A Pyridazine derivatives and their use as therapeutic agents
05/26/2010CN101712618A Two crystal form materials of salvianolic acid A, preparation method as well as medicine compound and application thereof
05/26/2010CN101711844A Chinese medicinal composition for relieving stagnation and freeing network vessels
05/26/2010CN101711839A Medicine for treating diabetes
05/26/2010CN101711832A Traditional Chinese medicine composition for treating diabetes and preparation method
05/26/2010CN101711812A Method for preparing oleanolic acid capsule of Chaenomeles speciosa Nakai leaves
05/26/2010CN101711798A Preparation used for lowering blood fat and lowering blood sugar
05/26/2010CN101711782A Purely natural traditional Chinese medicine for treating diabetes
05/26/2010CN101711760A Thiophene derivative with excellent function of blood glucose reduction and adduct PPAR alpha/gamma double agonists thereof
05/26/2010CN101711740A Method for preparing targeted curcumin nanoparticles for treating ulcerative colitis
05/26/2010CN101711738A Oral pharmaceutical composition of Fenofibrate
05/26/2010CN101711733A Nano gold essential oil liquid
05/26/2010CN101711582A Composition containing American ginseng extract and probiotics and application thereof
05/26/2010CN101190007B Nutrition food containing bran
05/26/2010CN101147807B Substances for preventing and treating autoimmune diseases
05/26/2010CN101129604B Antihypelipidemic traditional Chinese medicine producing method
05/26/2010CN101104618B Long chain alkyl berberine salt derivative, synthetic method and use
05/26/2010CN101068779B 9,10-secopregnane derivative and medicine
05/26/2010CN101066258B Inclusion compound of higher fatty alcohol and its preparation
05/26/2010CN101062114B Method for distilling flavone from tartary buckwheat bran
05/26/2010CN101057976B Substances for preventing and treating autoimmune diseases
05/26/2010CN101031540B Hexafluoroisopropanol substituted ether derivatives
05/26/2010CN101023772B Gastrodia-walnut health-care sweet
05/26/2010CN101019664B Production process of instant abalone in soft package
05/26/2010CN101011106B Feed addictive for livestock and fowl and producing process thereof
05/25/2010US7723503 nucleotide sequences or complements that encode polypeptides having omega-3 desaturase and delta-12 desaturase enzyme activity, used for making polyunsaturated fatty acids; additives for drugs, nutritional compositions, animal feeds, as well as other products such as cosmetics
05/25/2010US7723499 polynucleotides that code for polypeptides comprising amino acid sequences that preferentially recognize and bind to angiopoietins
05/25/2010US7723490 Process for correction of a disulfide misfold in Fc molecules
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723390 Thyroid hormones or their salts in capsule or in swallowable uniform soft-gel gelatin matrices for treatment of hypothyroidism
05/25/2010US7723366 Cardiovascular disorders; antidiabetic agents; anticancer agents
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723355 7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods
05/25/2010US7723344 Dipeptidyl peptidase inhibitors
05/25/2010US7723342 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
05/25/2010US7723340 mitogen-activated protein kinase 8 inhibitors, used for treating or preventing cancer, cardiovascular diseases, renal diseases, autoimmune disorders, inflammatory disorders, vision defects, ischemia-reperfusion injuries, pain and hypertension
05/25/2010US7723334 Highly selective norepinephrine reuptake inhibitors and methods of using the same
05/25/2010US7723331 Thienopyrimidine compounds and uses thereof
05/25/2010US7723323 fused 1,2,4-triazoles for modulating the activity of 11 beta -hydroxysteroid dehydrogenase type 1 (11 beta HSD1) and the use of these compounds as pharmaceutical compositions has been described. Also a novel class of fused 1,2,4-triazoles, their use in therapy, pharmaceutical compositions
05/25/2010US7723304 Hypotensive agents; cardiovascular disorders; wound healing agents; antitumor agents; antidiabetic agents ; nephropathy; gastrointestinal disorders; alopecia; blood disorders ; urogenital disorders
05/25/2010CA2584975C Drug and food or drink for improving pancreatic functions
05/25/2010CA2489337C Indole derivatives useful as histamine h3 antagonists
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/25/2010CA2426263C Nateglinide-containing preparation
05/25/2010CA2403423C Tri-aryl-substituted-ethane pde4 inhibitors
05/25/2010CA2395461C Methods of modulating c-kit tyrosine kinase function with indolinone compounds
05/25/2010CA2375923C Devices and compounds for treating arterial restenosis
05/25/2010CA2326874C Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
05/25/2010CA2314156C Pyrrole substituted 2-indolinone protein kinase inhibitors
05/20/2010WO2010057126A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
05/20/2010WO2010056910A2 Methods of treating cardiovascular disorders
05/20/2010WO2010056865A1 Quinoline derivatives as ion channel modulators
05/20/2010WO2010056726A1 Compositions and methods for treating diabetes
05/20/2010WO2010056708A1 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
05/20/2010WO2010056630A1 Triazolopyrimidinones and methods of use thereof
05/20/2010WO2010056549A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010WO2010056527A2 Fused heterocyclic compounds as ion channel modulators
05/20/2010WO2010056230A1 3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors
05/20/2010WO2010056145A1 Method for moderately increasing the proton conductivity of biological membranes with the aid of mitochondria-targeted delocalized cations
05/20/2010WO2010055490A2 Phytocomplex from bergamot fruit, process of manufacture and use as dietary supplement and in the pharmaceutical field
05/20/2010WO2010055170A1 Pyrimidinium derivatives for use in the treatment or prevention of diabetes
05/20/2010WO2010054764A1 Heteroaromatic compounds for use as hif inhibitors
1 ... 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 ... 1298